Celltrion
068270.KS
#656
Rank
NZ$50.40 B
Marketcap
$243.37
Share price
3.23%
Change (1 day)
30.88%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$23.56 B

According to Celltrion 's latest financial reports the company's total assets are NZ$23.56 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31NZ$7.35 B5.69%
2021-12-31NZ$6.96 B8.38%
2020-12-31NZ$6.42 B29.85%
2019-12-31NZ$4.94 B5.81%
2018-12-31NZ$4.67 B7.48%
2017-12-31NZ$4.35 B25.97%
2016-12-31NZ$3.45 B5.08%
2015-12-31NZ$3.28 B21.6%
2014-12-31NZ$2.70 B18.29%
2013-12-31NZ$2.28 B12.22%
2012-12-31NZ$2.03 B30.92%
2011-12-31NZ$1.55 B16.57%
2010-12-31NZ$1.33 B98.01%
2009-12-31NZ$0.67 B-3.29%
2008-12-31NZ$0.69 B711.4%
2007-12-31NZ$85.86 M